首页> 美国卫生研究院文献>OncoTargets and therapy >Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer
【2h】

Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer

机译:依维他命和小ber碱对人大肠癌miR-429癌基因的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Loss of epithelial organization and deregulated microRNAs are hallmarks of malignant carcinomas, but the relationship between them has been poorly understood. This study was designed to investigate the changes in the expression of E-cadherin, Par3, and miR-429 during the development of human colorectal cancer (CRC). E-cadherin and Par3 levels were quantitatively detected by immunohistochemistry and Western blotting. An in vitro culture of colorectal tissue was established to analyze the effect of berberine (BER) and evodiamine (EVO) on the level of miR-429. Our results suggested that E-cadherin and Par3 were remarkably decreased in tumor tissues compared with those in normal tissues, and miR-429 was upregulated in tumor tissues. After treatment of BER and EVO, the level of miR-429 was lower in tumor tissues than in normal tissues. This study investigated the potential relationship between miR-429, E-cadherin, and Par3 in CRC. The data suggested that BER and EVO can be potential therapeutic agents for CRC, as they downregulated the expression level of miR-429.
机译:上皮组织的丧失和microRNA的失调是恶性肿瘤的标志,但人们对它们之间的关系了解甚少。这项研究旨在调查人类结直肠癌(CRC)发生期间E-钙粘蛋白,Par3和miR-429表达的变化。通过免疫组织化学和蛋白质印迹法定量检测E-钙粘蛋白和Par3水平。建立了大肠组织的体外培养物,以分析小ber碱(BER)和依夫二胺(EVO)对miR-429水平的影响。我们的结果表明,与正常组织相比,肿瘤组织中的E-cadherin和Par3显着降低,而在肿瘤组织中miR-429被上调。治疗BER和EVO后,肿瘤组织中的miR-429水平低于正常组织。这项研究调查了miR-429,E-cadherin和Par3在CRC中的潜在关系。数据表明BER和EVO可能下调miR-429的表达水平,因此可能是CRC的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号